Mesoblast files October 2025 Form 6-K update

Mesoblast Limited submitted a Form 6-K as a foreign private issuer for October 2025.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Mesoblast Limited submitted a Form 6-K as a foreign private issuer for October 2025. The report states that on October 7, 2025, the company filed a news release announcement with the Australian Securities Exchange, which is attached as Exhibit 99.1 and incorporated by reference. The filing itself mainly serves to furnish this press release to U.S. investors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Mesoblast (MEOBF) disclose in this October 2025 Form 6-K?

Mesoblast discloses that it has filed a news release announcement with the Australian Securities Exchange. That ASX release, dated October 7, 2025, is attached to the Form 6-K as Exhibit 99.1 and incorporated by reference.

What is attached to Mesoblast’s (MEOBF) Form 6-K as Exhibit 99.1?

Exhibit 99.1 is a press release of Mesoblast Limited dated October 7, 2025. The Form 6-K primarily serves to furnish this Australian Securities Exchange announcement to U.S. markets and investors.

Why did Mesoblast (MEOBF) file this Form 6-K in October 2025?

Mesoblast filed this Form 6-K to provide U.S. investors with a copy of a news release it lodged with the Australian Securities Exchange. The attached Exhibit 99.1 press release is incorporated into the Form 6-K by reference.

Who signed the October 2025 Mesoblast (MEOBF) Form 6-K?

The Form 6-K was signed on behalf of Mesoblast Limited by Company Secretary Paul Hughes. His electronic signature appears in the filing, dated October 7, 2025, confirming the company’s authorization of the report.

Under which form does Mesoblast (MEOBF) file its annual reports?

The filing indicates that Mesoblast files annual reports under cover of Form 20-F. This confirms its status and reporting framework as a foreign private issuer under U.S. securities regulations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 10/06/2025 - 08:09 PM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of October 2025

Commission File Number 001-37626

Mesoblast Limited

(Exact name of Registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s name into English)

Australia
(Jurisdiction of incorporation or organization)

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F ☑ Form 40-F ☐

INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On October 7, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new release announcement, which is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

Mesoblast Limited

/s/ Paul Hughes

Paul Hughes

Company Secretary

Dated: October 7, 2025

INDEX TO EXHIBITS



Item

99.1						Press release of Mesoblast Ltd, dated October 7, 2025.

Source: View Original Filing on SEC EDGAR